SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-536129
Filing Date
2016-04-11
Accepted
2016-04-11 06:04:32
Documents
7
Period of Report
2016-05-16
Effectiveness Date
2016-04-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A d164254ddef14a.htm DEF 14A 440216
2 GRAPHIC g164254ltr_pg01a.jpg GRAPHIC 5275
3 GRAPHIC g164254ltr_pg01b.jpg GRAPHIC 5751
4 GRAPHIC g164254not_pg01a.jpg GRAPHIC 5275
5 GRAPHIC g164254not_pg01b.jpg GRAPHIC 5751
6 GRAPHIC g164254pc_pg01a.jpg GRAPHIC 1603
7 GRAPHIC g164254pc_pg01b.jpg GRAPHIC 1710
  Complete submission text file 0001193125-16-536129.txt   477396
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33004 | Film No.: 161563827
SIC: 2834 Pharmaceutical Preparations